Global stem cell market is dominating the healthcare industry with its reliable and cost effective method of treatment with fewer side effects. Umbilical cord blood stem cells are one of the potential segments of stem cell market for growth in future.

1. UCB Stem Cell: New hope for cancer patients

2. 148 Pages
Report
Published Date: 21-Jan-2014

3. Description
Global stem cell market is dominating the healthcare industry with its
reliable and cost effective methods of treatments with fewer side effects.
Umbilical cord blood stem cells are one of the potential segments of stem
cell market for growth in future. Cord blood has huge potential to treat
chronic diseases such as cancer, diabetes, blood disease immune
diseases, etc. More than 80 genetic diseases were treated with cord blood
in current scenario.
Government authorities are supporting the research and clinical trials of
cord blood stem cell, which is currently increasing the interest of
healthcare companies to invest in research and commercialization. This is
therefore, compelling the market players to formulate market based
strategies. Cord blood stem cells are stored in controlled conditions due to
its lower volume higher cell count feature. Storage service market is
expected grow at 33.4% CAGR from 2013-2020.

4. Table of Content
1. Introduction
2. Executive Summary
3. Global UCB stem cell Market Overview
4. Key findings
5. Market Dynamics
6. Global UCB Stem Cell Market by Storage Service
7. Global UCB Stem Cell Market by Therapeutics
8. Global UCB Stem Cell Market by Application
9. Geography Analysis
10. Corporate Profiles and Analysis

5. Introduction
Scope of the Report
Objectives
Key Benefits
Key Deliverables
Key Audiences

6. Key Findings
Minimal invasive
techniques of
collection and
transferring
Reimbursement
and insurance
issues in
storage
Efficient
transferring
during
treatment
Efficient
extraction of
cord blood
Storage service
for maintaining
viability
Top ten factors
impacting UCB
stem cell
market
Positive
engraftment of
tissue
Government
regulation and
intervention
Ethical issues in
storage and
application
Cost of
treatment
Availability of
treatment and
sample

7. Mar ket Dynamics
Market
Dynamics
Key Market
Drivers
Minimal
invasive
methods
Treatment
on chronic
diseases
Cost
effective
therapy
and
storage
Market
Restraints
Easy
extraction
methods
Intact
genetic
structure
Government
regulations
and
intervention
Legal and
ethical
issues during
collection
Availability
of right type
of donor
Higher cost
of therapies

8. Market by Storage Service
Market by Storage
Service
Public cord blood
banks
Private cord blood
banks

9. SINGAPORE CORD BLOOD BANK INVENTORY AND TRANSPLANT (2005-2013)
Singapore cord blood has increased in number of cord blood inventory due to
increase in government policies and awareness program conducted for cord
blood donation. Practical application of this stem cell transplant is also
increased with increase in commercialization of stem cell transplant and
other transplant application. Market for cord blood stem cell transplant is
expecting more advantage that is competitive by providing cost effective
therapies in future.

10. Market by Therapeutics
Diabetes
Cancer/
Oncology
diseases
Blood diseases
Market by
Therapeutics
Other
diseases
Metabolic
Disorders
Immune
Disorders

11. GROWTH IN DISEASE TREATED VS. CLINICAL TRIALS
(2008-2012)
According to research conducted by BioInformant Worldwide on the stem
cell industry, it is observed that frequency of clinical trials for cord blood
research is increased by 144% during past five years. According to clinical
trials.gov. ,there were 78 clinical trials conducted for cord blood stem cell in
2008 compared to 191 in 2012. This will shows the increased percentage of
cord blood clinical trials by more than 145%.
2008
2009
Disease Treated
2010
2011
Cord blood clinical trials
2012

12. Market by Application
• Autologous transplant
• Allogeneic
transplant
Stem Cell
Transplant
Regenerative
Medicine
• Regenerative
Medicine
• Transplant
Medicine
Transplant
Medicine
Others
•Blood Transfusion
•Cell Based
Genetics

13. Top Market Players
 Cytori Therapeutics Inc.
 Advanced Cell Technology, Inc. (USA)
 CALIFORNIA STEM CELL
 Osiris Therapeutics
 NeoStem Inc.
 Geron Corporation
 Opexa Therapeutics, Inc.
 Athersys, Inc.
 Pluristem Therapeutics Inc.
 Mesoblast Limited

14. Your feedback is important to us
What would you like to know more about this Study ?
 Global Industry Analysis
 Market Size
 Market Share
 Market Trends
Opportunities and Forecast
Please inform us on : http://www.alliedmarketresearch.com/contact-us

15. http://www.alliedmarketresearch.com/ste
m-cell-umbilical-cord-blood-UCB-market